A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NOH
Long Form : neurogenic orthostatic hypotension
No. Year Title Co-occurring Abbreviation
2019 (r)Alpha Lipoic Acid Is a Safe, Effective Pharmacologic Therapy of Chronic Orthostatic Hypotension Associated with Low Sympathetic Tone. BP
2019 Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension. AS, TH
2019 Cerebellar impairment during an orthostatic challenge in patients with neurogenic orthostatic hypotension. LBNP
2019 Chemical pharmacotherapy for the treatment of orthostatic hypotension. nSH
2019 Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases. BP, MSA, PAF, PD
2019 Evidence of Impaired Cerebellar Connectivity at Rest and During Autonomic Maneuvers in Patients with Autonomic Failure. LBNP, VM
2019 Neglected cause of recurrent syncope: a case report of neurogenic orthostatic hypotension. ---
2019 Neurogenic orthostatic hypotension impairs information processing speed and attention. DBP, HUT, IPS, SBP, SDMT
2019 Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer. PD
10  2019 Reduced brainstem functional connectivity in patients with peripheral autonomic failure. PCC
11  2019 Role of nurses and nurse practitioners in the recognition, diagnosis, and management of neurogenic orthostatic hypotension: a narrative review. BP
12  2019 Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension. PROs, QOL
13  2019 Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease. AF, BP
14  2018 Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers. MSA, PD
15  2018 Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease. BG, PD, WML
16  2018 Impaired cortical autonomic responses during sympathetic activation in Neurogenic Orthostatic Hypotension characterized by post-ganglionic autonomic dysfunction. BOLD, CAN, DB, VM
17  2018 Impaired cortical autonomic responses during sympathetic activation in neurogenic orthostatic hypotension characterized by postganglionic autonomic dysfunction. BOLD, CAN, DB, VM
18  2018 Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease. AE, BP, OHDAS, OHQ, OHSA, PD
19  2018 Orthostatic hypotension for the cardiologist. FDA
20  2018 Roles of cardiac sympathetic neuroimaging in autonomic medicine. 123I-MIBG, NET
21  2018 Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials. CrIs, RRs, s-SBP
22  2018 Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. BP, NE
23  2017 Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension. OHQ
24  2017 Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension. ---
25  2017 The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. ---
26  2016 Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension. AEs, LHH, NNH, NNT, OHSA
27  2016 Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. ICERs, QALYs
28  2016 Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension. MD, OHQ, RCTs, SBP
29  2016 Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303). AE
30  2015 Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension. BRS, LFDBP, MIBG, PD, UPDRS
31  2015 Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease. ---
32  2015 Diagnosing and treating neurogenic orthostatic hypotension in primary care. BP
33  2015 Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). AE, OHQ, OHSA, PD, s-SBP
34  2015 Droxidopa in neurogenic orthostatic hypotension. BP, MSA, PAF, PD
35  2015 Managed care approach to the treatment of neurogenic orthostatic hypotension. ---
36  2015 Neurogenic orthostatic hypotension: pathophysiology and diagnosis. ---
37  2015 Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions. ---
38  2014 A practical guide to the treatment of neurogenic orthostatic hypotension. ---
39  2014 Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. BP, OHQ
40  2014 Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). OHQ, PD
41  2014 Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. PD
42  2012 Mortality and prognosis in patients with neurogenic orthostatic hypotension. ---
43  2012 The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. OHQ
44  2010 Cardiac ectopy in chronic autonomic failure. CAF, MSA, PAF, PD
45  2009 Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension. PAF, PD
46  2008 Attenuated pre-ejection period response to tyramine in patients with cardiac sympathetic denervation. PAF, PD, PEP
47  2008 Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension. DHPG, NE, PAF, PD
48  2007 Pyridostigmine in the treatment of orthostatic intolerance. DBP
49  2003 Norepinephrine precursor therapy in neurogenic orthostatic hypotension. L-AADC, L-DOPS, NE
50  2003 Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. DHPG, EPI, MN, MSA, NE, NMN, PAF
51  1998 A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. ---
52  1995 [Cardiovascular alpha-, beta 1- and beta 2-adrenoceptor functions in neurogenic orthostatic hypotension]. IP, NA, NOH-I